Next Article in Journal
Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment
Next Article in Special Issue
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy
Previous Article in Journal / Special Issue
Immune History and Influenza Vaccine Effectiveness
Article Menu

Export Article

Open AccessReview
Vaccines 2018, 6(2), 29; https://doi.org/10.3390/vaccines6020029

Clinical Advances in Viral-Vectored Influenza Vaccines

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Headington, Oxford OX3 DQ, UK
*
Author to whom correspondence should be addressed.
Received: 19 April 2018 / Revised: 21 May 2018 / Accepted: 21 May 2018 / Published: 24 May 2018
Full-Text   |   PDF [635 KB, uploaded 24 May 2018]

Abstract

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate disease. Unfortunately, influenza vaccine composition needs to be updated annually due to antigenic shift and drift in the viral immunogen hemagglutinin (HA). There are a number of alternate vaccination strategies in current development which may circumvent the need for annual re-vaccination, including new platform technologies such as viral-vectored vaccines. We discuss the different vectored vaccines that have been or are currently in clinical trials, with a forward-looking focus on immunogens that may be protective against seasonal and pandemic influenza infection, in the context of viral-vectored vaccines. We also discuss future perspectives and limitations in the field that will need to be addressed before new vaccines can significantly impact disease levels. View Full-Text
Keywords: viral vectors; influenza; clinical trials viral vectors; influenza; clinical trials
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Sebastian, S.; Lambe, T. Clinical Advances in Viral-Vectored Influenza Vaccines. Vaccines 2018, 6, 29.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top